Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/29/2026, 7:19:20 PM
Content snapshot
{ "sides": [ { "label": "Eliminate (senolytic)", "hypothesis_ref": "hypothesis:h-58e4635a" }, { "label": "Modulate (senomorphic)", "hypothesis_ref": "hypothesis:SDA-2026-04-16-hyp-daadc5c6" } ], "resolution_criterion": "PROCEED-AD or comparable senescence-targeted clinical readout (target 2027): does combined senolytic depletion (e.g. dasatinib + quercetin) outperform sustained SASP-modulation (e.g. JAK inhibition) on cognitive endpoints in MCI/early-AD over a 24-month window?", "state": "open", "pots": [ 0, 0 ], "n_bettors_per_side": [ 0, 0 ], "domain": "neurodegeneration", "proposer_id": "anonymous" }